期刊文献+

抗肿瘤注射剂的合理使用 被引量:3

The Rational Administration and Use of Cancer Therapeutic Injections
暂未订购
导出
摘要 目的: 促进抗肿瘤注射剂的合理使用,提高临床使用的安全性和有效性。方法: 查阅分析抗肿瘤药物的文献资料,总结临床常用抗肿瘤注射剂的配置要求、联合用药的给药顺序、药物间相互作用以及患者用药的注意事项等在抗肿瘤注射剂使用中的常见问题。结果和结论:抗肿瘤注射剂配置和使用过程复杂,影响因素多,药师要更多的参与协助临床。 Objective: To improve the rational use of cancer therapeutic injections and promote the clinical safety and efficacy use of them. Methods: Summarizing the common problems when using of cancer therapeutic injections such as the requirements when preparing the administration of intravenous admixture, the sequence of combination chemotherapy, the drug interaction and general precautions, according to the literature and information of drugs. Results and Conelusions: The preparing of administration and using process of cancer therapeutic injections are complicated and there are many influencing factors so that pharmacist should participate more in the administration and use of cancer therapeutic injections in their clinical use.
作者 戴媛媛 刘康
出处 《药品评价》 CAS 2010年第6期50-53,共4页 Drug Evaluation
关键词 抗肿瘤注射剂 配置 给药顺序 相互作用 Cancer therapeutic injections Preparation of administration Sequence Injections
  • 相关文献

参考文献12

  • 1Stewart CF,Fleming RA.Compatibility of cisplatin and fluorourscil in 0.9%sodium chloride infection[J].Am J Hosp Pharm.1990,47(6),1373-7.
  • 2D Arcy PF.Reactions and interactions in handling anticancer drugs[J].Drug Intell Clin Pharm.1983,17(7-8),532-8.
  • 3Zhang Y,Xu QA,Trissel LA,et al.Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions[J].Ann Pharmacother.1997,31(12):1465-70.
  • 4Trissel LA,Bready BB.Tmbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection[J].Am J Hosp Pharm.1992,49(7):1716.
  • 5Trissel LA,Saenz CA,Ogundele AB,et al.Physical compatibility of pemetrexed disodium with other drugs simulated Y-site administration.Am J Health-Syst Pharm 2004,61(21):2289-93.
  • 6戴媛媛,汤致强.化疗药物渗漏预防和处理[J].首都医药,2007,14(06X):37-37. 被引量:2
  • 7Grasselli G,Viganò L,Capri G,et al.Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metasatic breast cancer[J].J Clin Oncol 2001,19(8):2222-31.
  • 8Danesi R,Innocenti F,Fogli S,et al.Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients[J].Br J Clin Pharmacol.2002,53(5):508-18.
  • 9Boisdron-Celle M,Craipeau C,Brienza S,et al.Influence of oxaliplatin on 5-fluorouracil plasma clearance and Clinical consequences[J].Cancer Chemother Pharmacol.2002,49(3):235-43.
  • 10Steinbild S,Baas F,Gmehling D,et al.Phase Ⅰ study of BAY 439006(Sorafenib),a Raf kinase and VEGFR inhibitor,combined with irinotecan(CPT-11)in advanced solid tumors[J].J Clin Oncol.2005,23(16S):3115-3120.

二级参考文献1

  • 1Albanell J,Baselga JL.Systemic therapy emergencies.Semin Oncol,2000,27:347~361

共引文献1

同被引文献38

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部